Current Advances in Hereditary Renal Diseases and Cancers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 December 2024 | Viewed by 22
Special Issue Editors
Interests: kidney cancer; prostate cancer; kidney transplantation; metabolomics
Special Issues, Collections and Topics in MDPI journals
Interests: kidney cancer; prostate cancer; molecular markers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
High-throughput technologies, such as genomics, proteomics, and metabolomics, have led to remarkable advancements in the fields of renal diseases and cancers in recent decades.
These technologies have enabled the identification of the mechanistic pathways underlying renal diseases, leading to the emergence of novel therapeutic targets. Notably, complement and complement regulatory proteins have been reevaluated for their roles in disease pathogenesis, paving the way for innovative therapeutic approaches.
Renal cell carcinoma (RCC) can arise in either sporadic or hereditary forms. Despite ongoing research, the exact pathogenesis of RCC remains incompletely understood. Studies consistently show that alterations in metabolic pathways play a significant role in RCC development, with several mutated genes crucial for regulating cellular metabolism. Improved understanding of RCC genomic features could enhance screening protocols and management strategies for high-risk individuals, ultimately leading to better patient prognoses.
This Special Issue invites articles that highlight recent developments or ongoing efforts aimed at unraveling the pathogenesis of genetic renal diseases, congenital anomalies of the kidney and the urinary tract (CAKUT), and hereditary renal cancers.
Prof. Dr. Giuseppe Lucarelli
Dr. Francesco Lasorsa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- renal diseases
- CAKUT
- nephropathies
- hereditary renal cancers
- renal cell carcinoma
